Scientific preventive treatment to accelerate the process of tuberculosis control

doi:10.3969/j.issn.1000-6621.2020.04.004

Abstract

Abstract:

World Health Organization (WHO) have set a grand goal of eliminating tuberculosis (TB) by 2035, however, it is unrealistic to achieve this only relying on the measure of early detection and cure TB patients. Measures such as cutting off transmission routes and protecting susceptible populations are particularly important. There are a large number of people in China who are potentially infected with TB, and it is impossible for all the people to receive the preventive treatment. WHO has recommended people to identify at-risk populations for latent tuberculosis infection testing and treatment, but considering China’s national conditions, WHO’s recommendations are not entirely applicable to China. Therefore, it is of great significance to identify high TB risk population scientifically among people infected with Mycobacterium tuberculosis in our country and carry out preventive treatment.

Key words: Tuberculosis, Latent tuberculosis, Antibiotic prophylaxis, Population Surveillance, Intervention studies, Comment, Preventive therapy

LU Peng,CHENG Jun,LU Xi-wei,LIU Er-yong,ZHOU Lin,LU Wei. Scientific preventive treatment to accelerate the process of tuberculosis control[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 316-321. doi: 10.3969/j.issn.1000-6621.2020.04.004

Figures/Tables 3

References 32

[1]	World Health Organization. Factsheet: post-2015 global TB strategy and targets. Geneva: World Health Organization, 2015.
[2]	刘二勇, 周林, 成诗明 . 结核分枝杆菌潜伏性感染及预防性治疗研究进展的系统评价. 中国防痨杂志, 2013,35(4):231-239.
[3]	Huynh GH, Klein DJ, Chin DP , et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Medicine, 2015,13(1):88.
[4]	World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
[5]	Velayutham BRV, Nair D, Chandrasekaran V , et al. Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB Control programme in South India. PLoS One, 2014,9(3):e88045.
[6]	Rangaka MX, Cavalcante SC, Marais BJ , et al. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet, 2015,386(10010):2344-2353.
[7]	Houben RM, Dodd PJ . The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med, 2016,13(10):e1002152.
[8]	Dye C, Glaziou P, Floyd K , et al. Prospects for tuberculosis elimination. Annu Rev Public Health, 2013,34:271-286.
[9]	World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization, 2018.
[10]	Adams S, Ehrlich R, Baatjies R , et al. Predictors of discordant latent tuberculosis infection test results amongst South African health care workers. BMC Infectious Diseases, 2019,19(1):131.
[11]	Behr MA, Edelstein PH, Ramakrishnan L . Revisiting the time-table of tuberculosis. BMJ, 2018,362:k2738.
[12]	Sloot R, Schim van der Loeff MF, Kouw PM , et al. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit Care Med, 2014,190(9):1044-1052.
[13]	Miller FJW, Seal RME, Taylor MD . Tuberculosis in Children. Evolution-Control-Treatment, 1963,188(13):1162-1163.
[14]	Comstock GW, Livesay VT, Woolpert SF . The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol, 1974,99(2):131-138.
[15]	王黎霞, 成诗明, 陈伟 . 学校结核病防治工作手册. 北京: 军事医学科学出版社, 2012.
[16]	World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low-and middle-income countries. Geneva:World Health Organization, 2012.
[17]	Huang H, Yuan G, Du Y , et al. Effects of preventive therapy for latent tuberculosis infection and factors associated with treatment abandonment: A cross-sectional study. J Thorac Dis, 2018,10(7):4377-4386.
[18]	柳吾录, 赵天荣, 薛葆 , 等. 异烟肼预防大学生肺结核发病4年观察. 中国防痨杂志, 1995,17(3):106-107.
[19]	王娟 . 大中学生预防性抗结核治疗效果调查分析. 临床肺科杂志, 2011,16(2):294-295.
[20]	刘庆福 . 高等院校结核病防治措施的探索. 中国防痨杂志, 2010,32(3):147-150.
[21]	朱俊芳, 刘伟江, 刘柏辉 , 等. 大中专学生预防性抗结核治疗效果调查分析. 赣南医学院学报, 2008,28(3):432-433.
[22]	单铁英, 乔俊红, 贾力品 . 河北省某市大学生结核感染的预防性治疗. 河北北方学院学报, 2006,23(3):50-51.
[23]	刘玉清, 屠德华, 安燕生 , 等. 大学生结核病控制的研究:(二)结核感染者的预防性治疗. 中国防痨杂志, 2005,27(3):139-142.
[24]	杜玉春, 刘伟江, 刘柏辉 . 大学生肺结核发病情况的回顾性调查. 赣南医学院学报, 2008,28(1):101-103.
[25]	易娴 . 学校结核感染者预防性治疗效果分析. 大家健康(上旬版), 2017,11(12):30.
[26]	李毓清, 潘小平 . 大学生结核菌素试验强阳性575例分析. 中国校医, 2007,21(1):78.
[27]	Wu X, Pang Y, Song Y , et al. Implications of a school outbreak of multidrug-resistant tuberculosis in Northern China. Epidemiol Infect, 2018,146(5):584-588.
[28]	段培真 . 短程化疗预防大学生结核病120例疗效观察. 陕西医学杂志, 2004,36(6):571-572.
[29]	Raviglione MC, Snider DE, Kochi A . Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA, 1995,273(3):220-226.
[30]	Morrison J, Pai M, Hopewell PC . Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis, 2008,8(6):359-368.
[31]	钟球, 成诗明, 周林 . 学校结核病筛查技术手册. 北京: 人民卫生出版社, 2018.
[32]	王倪, 张慧, 黄飞 , 等. 在中学开展结核菌潜伏感染者预防性治疗的可行性研究. 疾病监测, 2017,32(1):43-47.